SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-17-001204
Filing Date
2017-07-06
Accepted
2017-07-06 16:01:48
Documents
1
Period of Report
2017-07-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3910
  Complete submission text file 0001123292-17-001204.txt   5416
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Issuer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZYNERBA PHARMACEUTICALS, INC. 80 W. LANCASTER AVENUE DEVON PA 19333
Business Address
Rask Cynthia Ann (Reporting) CIK: 0001648767 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37526 | Film No.: 17952085